Clomiphene Citrate for Idiopathic Oligoasthenozoospermia in Infertile Men

This clinical trial focuses on understanding whether the drug clomiphene citrate can improve sperm quality in men who have difficulty with fertility due to a condition called idiopathic oligoasthenozoospermia, which affects sperm count and movement. The study is important because it aims to find out if clomiphene citrate can offer a new way to help these men increase their chances of conception, addressing a significant challenge for couples trying to have children. Participants in the study will receive either clomiphene citrate or a placebo, which looks like the drug but contains no active ingredients. The study will monitor changes in sperm count and movement to see if clomiphene citrate makes a difference. It will also keep track of any side effects participants experience to assess the safety of the treatment. This approach ensures that any improvements in sperm parameters can be confidently attributed to clomiphene citrate.